The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 03, 2021
Filed:
Mar. 20, 2020
Applicant:
21c Bio, Paris, FR;
Inventor:
Daniel Zagury, Paris, FR;
Assignee:
21C Bio, Paris, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); C07K 16/00 (2006.01); C07K 16/42 (2006.01); A61K 39/21 (2006.01); A61K 38/21 (2006.01); C12N 7/00 (2006.01); A61K 39/09 (2006.01); A61P 31/18 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 39/21 (2013.01); A61K 38/212 (2013.01); A61K 38/217 (2013.01); A61K 39/092 (2013.01); A61P 31/18 (2018.01); C12N 7/00 (2013.01); A61K 45/06 (2013.01); A61K 2039/5254 (2013.01);
Abstract
In the present invention, the Applicant provides a novel method for preventing or treating an infectious disease in a subject in need thereof. In particular said method comprise the administration of a combination, pharmaceutical combination, medicament or kit-of-parts comprising a first part comprising a CD8 vaccine specific for at least one infectious disease-related antigen, optionally a second part comprising an interferon alpha blocking agent, and a third part comprising a type III interferon and/or an agent stimulating the production of type III interferon.